Next earnings date: 14 Oct 2025
Abbott Laboratories – NYSE:ABT
Abbott Laboratories stock price today
$131.51
+16.51
+14.37%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market open
Closed in about 3 hours
Abbott Laboratories stock price monthly change
+10.33%
month
Abbott Laboratories stock price quarterly change
+10.33%
quarter
Abbott Laboratories stock price yearly change
+4.74%
year
Abbott Laboratories key metrics
Market Cap | 196.64B |
Enterprise value | 206.86B |
P/E | 34.58 |
EV/Sales | 5.01 |
EV/EBITDA | 19.23 |
Price/Sales | 4.83 |
Price/Book | 5.01 |
PEG ratio | -13.22 |
EPS | 3.25 |
Revenue | 40.32B |
EBITDA | 9.18B |
Income | 5.63B |
Revenue Q/Q | 2.22% |
Revenue Y/Y | -2.84% |
Profit margin | 13.99% |
Oper. margin | 16.73% |
Gross margin | 54.7% |
EBIT margin | 16.73% |
EBITDA margin | 22.77% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeAbbott Laboratories stock price history
Abbott Laboratories stock forecast
Abbott Laboratories financial statements
Average Price Target
$139.69
Potential upside: 6.22%
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 9.97B | 1.37B | 13.78% |
|---|---|---|---|
| Sep 2023 | 10.14B | 1.43B | 14.16% |
| Dec 2023 | 10.24B | 1.59B | 15.56% |
| Mar 2024 | 9.96B | 1.22B | 12.29% |
| 2024-10-16 | 1.2 | 1.21 |
|---|
1.91%
Yield TTM
| Payout ratio | 65.3% |
|---|
| 2019 | 1.48% |
|---|---|
| 2020 | 1.32% |
| 2021 | 1.28% |
| 2022 | 1.72% |
| 2023 | 1.86% |
| Jun 2023 | 73354000000 | 35.95B | 49.01% |
|---|---|---|---|
| Sep 2023 | 72090000000 | 34.39B | 47.71% |
| Dec 2023 | 73214000000 | 34.38B | 46.97% |
| Mar 2024 | 72467000000 | 33.42B | 46.12% |
| Jun 2023 | 1.20B | -1.21B | -1.28B |
|---|---|---|---|
| Sep 2023 | 1.87B | -634M | -2.34B |
| Dec 2023 | 3.03B | -824M | -2.05B |
| Mar 2024 | 1.02B | -425M | -1.17B |
Abbott Laboratories alternative data
Abbott Laboratories Social Media Accounts
What are followers?
+1.48%
month
| May 2025 | 263583 |
|---|---|
| Jul 2025 | 278671 |
| Aug 2025 | 282801 |
ABT Nutrition Care Products
| 19 Feb 2023 | 56 | 5 | 0 | 9 | 0 |
|---|---|---|---|---|---|
| 26 Feb 2023 | 57 | 5 | 0 | 9 | 0 |
| 5 Mar 2023 | 60 | 4 | 0 | 9 | 0 |
| 12 Mar 2023 | 63 | 4 | 0 | 9 | 0 |
| 19 Mar 2023 | 66 | 5 | 0 | 9 | 0 |
| 26 Mar 2023 | 69 | 5 | 0 | 9 | 0 |
| 2 Apr 2023 | 71 | 4 | 0 | 9 | 0 |
| 9 Apr 2023 | 69 | 5 | 0 | 8 | 0 |
| 16 Apr 2023 | 66 | 4 | 0 | 8 | 0 |
| 23 Apr 2023 | 71 | 4 | 0 | 9 | 0 |
| 30 Apr 2023 | 67 | 4 | 0 | 9 | 0 |
| 7 May 2023 | 71 | 5 | 0 | 9 | 0 |
| 14 May 2023 | 64 | 5 | 0 | 9 | 0 |
| 21 May 2023 | 57 | 5 | 0 | 9 | 0 |
| 28 May 2023 | 65 | 5 | 0 | 9 | 0 |
| 4 Jun 2023 | 62 | 5 | 0 | 8 | 0 |
| 11 Jun 2023 | 62 | 5 | 0 | 8 | 0 |
| 18 Jun 2023 | 64 | 4 | 0 | 9 | 0 |
| 25 Jun 2023 | 63 | 4 | 0 | 9 | 0 |
| 2 Jul 2023 | 63 | 4 | 0 | 8 | 0 |
Numbers represent search interest relative to the highest point on the chart for the given region and time.
A value of 100 is the peak popularity for the term.
A value of 50 means that the term is half as popular.
A score of 0 means there was not enough data for this term.
What is job openings count?
| Aug 2023 | 2,101 |
|---|---|
| Sep 2023 | 2,182 |
| Oct 2023 | 2,212 |
| Nov 2023 | 2,332 |
| Dec 2023 | 2,096 |
| Jan 2024 | 2,139 |
| Feb 2024 | 2,401 |
| Apr 2024 | 2,282 |
| May 2024 | 2,458 |
| Jun 2024 | 2,415 |
| Jul 2024 | 2,494 |
| Dec 2024 | 2,344 |
| Jan 2025 | 2,182 |
| Feb 2025 | 2,402 |
| May 2025 | 2,381 |
| Jul 2025 | 2,753 |
| Aug 2023 | 115,000 |
|---|---|
| Sep 2023 | 115,000 |
| Oct 2023 | 115,000 |
| Nov 2023 | 115,000 |
| Dec 2023 | 115,000 |
| Jan 2024 | 115,000 |
| Feb 2024 | 114,000 |
| Mar 2024 | 114,000 |
| Apr 2024 | 114,000 |
| May 2024 | 114,000 |
| Jun 2024 | 114,000 |
| Jul 2024 | 114,000 |
Abbott Laboratories other data
70.70%
-1.80%
of ABT is owned by hedge funds
2.64K
-83
1.26B
-32.24M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jun 2023 | 0 | 8000 |
| Jul 2023 | 0 | 50000 |
| Aug 2023 | 0 | 10400 |
| Oct 2023 | 0 | 50000 |
| Dec 2023 | 0 | 15000 |
| Jan 2024 | 0 | 17500 |
| Feb 2024 | 0 | 12500 |
| Mar 2024 | 0 | 4459 |
| May 2024 | 0 | 32949 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Option | FUNCK, JR. ROBERT E. officer: EXECUTIV.. | Common shares without par value | 10,097 | $47 | $474,559 | ||
Option | FUNCK, JR. ROBERT E. officer: EXECUTIV.. | Common shares without par value | 10,097 | $47 | $474,559 | ||
Sale | FUNCK, JR. ROBERT E. officer: EXECUTIV.. | Common shares without par value | 10,097 | $104.57 | $1,055,823 | ||
Sale | FUNCK, JR. ROBERT E. officer: EXECUTIV.. | Common shares without par value | 10,097 | $104.57 | $1,055,823 | ||
Option | FUNCK, JR. ROBERT E. officer: EXECUTIV.. | Option (right to buy) | 10,097 | $47 | $474,559 | ||
Option | FUNCK, JR. ROBERT E. officer: EXECUTIV.. | Option (right to buy) | 10,097 | $47 | $474,559 | ||
Sale | EARNHARDT LISA D officer: EXECUTIVE VICE PRESIDENT | Common shares without par value | 22,852 | $106.25 | $2,428,116 | ||
Sale | SALVADORI DANIEL GESUA SIVE officer: EXECUTIV.. | Common shares without par value | 963 | $118.5 | $114,116 | ||
Sale | SALVADORI DANIEL GESUA SIVE officer: EXECUTIV.. | Common shares without par value | 963 | $118.5 | $114,116 | ||
Sale | MORRONE LOUIS H. officer: EXECUTIVE VICE PRESIDENT | Common shares without par value | 801 | $118.5 | $94,919 |
| Patent |
|---|
Application Filling date: 4 Mar 2021 Issue date: 8 Sep 2022 |
Application Filling date: 6 Aug 2020 Issue date: 1 Sep 2022 |
Grant Filling date: 15 Apr 2021 Issue date: 30 Aug 2022 |
Grant Design: Reagent container Filling date: 17 Dec 2020 Issue date: 30 Aug 2022 |
Grant Filling date: 12 Mar 2021 Issue date: 23 Aug 2022 |
Grant Filling date: 17 Apr 2019 Issue date: 23 Aug 2022 |
Application METHODS FOR REDUCING THE INCIDENCE OF OXIDATIVE STRESS USING HUMAN MILK OLIGOSACCHARIDES, VITAMIN C AND ANTI-INFLAMMATORY AGENTS Filling date: 25 Apr 2022 Issue date: 11 Aug 2022 |
Grant Filling date: 12 Mar 2021 Issue date: 2 Aug 2022 |
Grant Filling date: 12 Mar 2021 Issue date: 2 Aug 2022 |
Grant Utility: Nutritional products having improved lipophilic solubility and bioavailability in an easily mixable form Filling date: 28 Jul 2016 Issue date: 2 Aug 2022 |
| Quarter | Transcript |
|---|---|
| Q1 2024 17 Apr 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 24 Jan 2024 | Q4 2023 Earnings Call Transcript |
| Q1 2023 9 Jan 2024 | Q1 2023 Earnings Call Transcript |
| Q3 2023 18 Oct 2023 | Q3 2023 Earnings Call Transcript |
Abbott Laboratories: FreeStyle Libre CGMs And EPD Business Driving Positive Momentum
Abbott Laboratories: Why Wall Street's Skepticism Misses The Real Story
Revisiting Senseonics After 4 Years: Still A Big Investment Opportunity
Abbott Laboratories: Strong Q4 Results And Bullish Outlook
AbbVie Has Immense Cash Flow Potential
Boston Scientific Corporation: Solid Financials And Upward Continuation
My New Year's Resolution For 2025: Invest $10,000 In These 6 Stocks
Abbott Laboratories: A Future-Driven Pharma Brand With A Robust Pipeline
Best Way To Invest $100,000: Build An 8-Stock Portfolio For Growth And Value
-
What's the price of Abbott Laboratories stock today?
One share of Abbott Laboratories stock can currently be purchased for approximately $131.51.
-
When is Abbott Laboratories's next earnings date?
Abbott Laboratories is estimated to report earnings on Tuesday, 14 Oct 2025.
-
Does Abbott Laboratories pay dividends?
Yes, Abbott Laboratories pays dividends and its trailing 12-month yield is 1.91% with 65% payout ratio. The last Abbott Laboratories stock dividend of $0.47 was paid on 15 Feb 2022.
-
How much money does Abbott Laboratories make?
Abbott Laboratories has a market capitalization of 196.64B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 8.12% to 40.11B US dollars. Abbott Laboratories earned 5.72B US dollars in net income (profit) last year or $1.21 on an earnings per share basis.
-
What is Abbott Laboratories's stock symbol?
Abbott Laboratories is traded on the NYSE under the ticker symbol "ABT".
-
What is Abbott Laboratories's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Abbott Laboratories?
Shares of Abbott Laboratories can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Abbott Laboratories's key executives?
Abbott Laboratories's management team includes the following people:
- Mr. Robert B. Ford Chairman, Pres & Chief Executive Officer(age: 51, pay: $5,050,000)
- Mr. Robert E. Funck Jr. Executive Vice President of Fin. & Chief Financial Officer(age: 64, pay: $2,430,000)
- Mr. Hubert L. Allen Executive Vice President, Gen. Counsel & Sec.(age: 59, pay: $1,820,000)
- Mr. Daniel Gesua Sive Salvadori Executive Vice President and Group Pres of Established Pharmaceuticals & Nutritional Products(age: 46, pay: $1,690,000)
- Mr. John F. Ginascol Executive Vice President of Core Diagnostics(age: 66, pay: $1,680,000)
-
How many employees does Abbott Laboratories have?
As Jul 2024, Abbott Laboratories employs 114,000 workers.
-
When Abbott Laboratories went public?
Abbott Laboratories is publicly traded company for more then 45 years since IPO on 17 Mar 1980.
-
What is Abbott Laboratories's official website?
The official website for Abbott Laboratories is abbott.com.
-
Where are Abbott Laboratories's headquarters?
Abbott Laboratories is headquartered at 100 Abbott Park Road, North Chicago, IL.
-
How can i contact Abbott Laboratories?
Abbott Laboratories's mailing address is 100 Abbott Park Road, North Chicago, IL and company can be reached via phone at +224 6676100.
-
What is Abbott Laboratories stock forecast & price target?
Based on 11 Wall Street analysts` predicted price targets for Abbott Laboratories in the last 12 months, the avarage price target is $139.69. The average price target represents a 6.22% change from the last price of $131.51.
Abbott Laboratories company profile:
Abbott Laboratories
abbott.comExchange:
NYSE
Full time employees:
114,000
Industry:
Medical - Devices
Sector:
Healthcare
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
100 Abbott Park Road
North Chicago, IL 60064-6400
North Chicago, IL 60064-6400
CIK: 0000001800
ISIN: US0028241000
CUSIP: 002824100
